These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pancolitis during etanercept treatment of rheumatoid arthritis relapsing on the administration of further two TNF-alpha inhibitors. Actis GC; Lagget M; Pellicano R; Rosina F Int J Colorectal Dis; 2012 Apr; 27(4):547-8. PubMed ID: 21656142 [No Abstract] [Full Text] [Related]
24. Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis? Gabriel SE Arthritis Rheum; 2008 Mar; 58(3):637-40. PubMed ID: 18311805 [No Abstract] [Full Text] [Related]
35. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases. Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017 [No Abstract] [Full Text] [Related]
36. Etanercept in rheumatoid arthritis. Escalante A; del Rincón I N Engl J Med; 1999 Jun; 340(25):2000; author reply 2001. PubMed ID: 10383274 [No Abstract] [Full Text] [Related]
37. New drugs for rheumatoid arthritis. Messori A; Santarlasci B; Vaiani M N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436 [No Abstract] [Full Text] [Related]
38. The role of tumor necrosis factor inhibitors in patients with RA. Trethewey P JAAPA; 2002 Sep; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668 [No Abstract] [Full Text] [Related]
39. Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients. Carter CT; Changolkar AK; Scott McKenzie R J Med Econ; 2012; 15(2):332-9. PubMed ID: 22168788 [TBL] [Abstract][Full Text] [Related]